Biotech startups that raised a seed round in Europe
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Aptadir Therapeutics | Milan | Seed | $45.5M | 2026-09-29 |
| BioFluff | Paris | Seed | $2.5M | 2026-09-02 |
| NOUS | Lomazzo | Seed | $2.7M | 2026-07-15 |
| En Carta Diagnostics | Paris | Seed | $3.4M | 2026-07-10 |
| smartbax | Munich | Seed | $5.5M | 2026-06-30 |
| Graph Therapeutics | Klosterneuburg | Seed | $5.0M | 2026-06-22 |
| Imperagen | Manchester | Seed | $6.7M | 2026-05-20 |
| Alcolase | Copenhagen | Seed | $1.7M | 2026-05-18 |
8 rows of the CSV in 5 of its 18 columns.
- The 1,040 biotech startups in Europe whose last round is a seed round have raised $2.0B in total.
- 122 of them closed their most recent round in the last 12 months, $630.5M combined.
- The largest of those rounds is Aptadir Therapeutics' $45.5M seed round, dated September 2026.
- The most recent is SRTD Biotech's $35.2M seed round on 9 November 2026.
- HTGF (High-Tech Gruenderfonds) is an investor in 34 of them, more than any other fund.
- Health care is the most common other sector, with 703 companies (68%).
- 39% were founded in 2020 or later; the median founding year is 2018.
- The most common team size is 1 to 10 employees (63% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
30 of 1,040| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Aptadir Therapeutics | Aptadir Therapeutics develops RNA-based therapies for Myelodysplastic Neoplasms. | Biotech | Milan, Italy | Seed | $45.5M | 2026-09-29 | $47.1M | CDP Venture Capital, Angelini Ventures | 1 to 10 | 2024 |
| BioFluff | BioFluff creates plant-based fur, shearling, and plush for the fashion, interior, and toy industries. | Biotech | Paris, France | Seed | $2.5M | 2026-09-02 | $3.2M | SOSV, SOSV SF & NY (Fka IndieBio), Joyance Partners +1 | 1 to 10 | 2022 |
| NOUS | NOUS develops biotech ingredients for food, beverage, and nutraceutical products. | Biotech | Lomazzo, Italy | Seed | $2.7M | 2026-07-15 | $3.0M | Eatable Adventures | 1 to 10 | 2023 |
| En Carta Diagnostics | En Carta Diagnostics develops molecular diagnostic technologies for detecting DNA and RNA pathogens at the point of care. | Biotech | Paris, France | Seed | $3.4M | 2026-07-10 | $7.3M | CentraleSupélec Venture | 11 to 50 | 2022 |
| smartbax | Smartbax develops multi-targeted antibacterial compounds that are potent against multi-drug resistant bacteria. | Biotech | Munich, Germany | Seed | $5.5M | 2026-06-30 | $7.5M | HTGF (High-Tech Gruenderfonds), Boehringer Ingelheim Venture Fund | 1 to 10 | 2021 |
| Graph Therapeutics | Graph Therapeutics uses AI and multi-omics analysis of patient cells to develop precision immunology treatments. | Artificial intelligence | Klosterneuburg, Austria | Seed | $5.0M | 2026-06-22 | $9.4M | SquareOne Venture Capital, Merantix Capital | 1 to 10 | 2024 |
| Imperagen | Imperagen is a biotechnology company that researches enzyme engineering, artificial intelligence, and synthetic biology. | Artificial intelligence | Manchester, United Kingdom | Seed | $6.7M | 2026-05-20 | $11.0M | IQ Capital, Northern Gritstone | 11 to 50 | 2021 |
| Alcolase | Alcolase is a Danish life science start-up developing treatments for alcohol flushing. | Biotech | Copenhagen, Denmark | Seed | $1.7M | 2026-05-18 | $2.6M | Antler | 1 to 10 | 2021 |
| Tacalyx | Tacalyx develops cancer therapies that target tumor-associated carbohydrate antigens. | Biotech | Berlin, Germany | Seed | $12.9M | 2026-04-29 | $28.0M | HTGF (High-Tech Gruenderfonds), coparion, Kurma Partners +2 | 1 to 10 | 2019 |
| Omegga GmbH | Omegga GmbH develops in-ovo sexing technology that identifies male chicks before hatching to prevent their killing. | Artificial intelligence | Munich, Germany | Seed | $11.7M | 2026-04-24 | $11.7M | EIC Accelerator, GETTY | 1 to 10 | 2022 |
| Fermtech | Fermtech provides equipment that helps precision fermentation companies scale production processes. | Biotech | Oxford, United Kingdom | Seed | $3.3M | 2026-04-07 | $3.9M | Carbon13 | 1 to 10 | 2022 |
| Corryn Biotechnologies | Corryn Biotechnologies develops wound dressing devices for chronic and complex wounds. | Biotech | Morriston, United Kingdom | Seed | $662K | 2026-04-01 | $1.6M | SFC Capital, Innovate UK | 1 to 10 | 2021 |
| Cellevate | Cellevate develops cell culture systems for biotech research and production. | Biotech | Lund, Sweden | Seed | $2.2M | 2026-03-30 | $12.1M | European Innovation Council, Industrifonden, Onsight Ventures +1 | 11 to 50 | 2014 |
| Cellbricks Therapeutics | Cellbricks Therapeutics is a biotech company developing methods for replacing tissue and organs. | Biotech | Berlin, Germany | Seed | $8.1M | 2026-03-25 | $11.6M | b.value AG, Brooks Hill Partners | 11 to 50 | 2016 |
| ENZIDIA | ENZIDIA develops enzyme acceleration technology for biomanufacturing. | Biotech | Kongens Lyngby, Denmark | Angel | $241K | 2026-03-16 | $865K | Innovation Fund Denmark | 1 to 10 | 2024 |
| Amatera | Amatera is a biotechnology research company that develops new coffee varieties. | Biotech | Paris, France | Seed | $7.0M | 2026-03-04 | $8.6M | AgFunder, Joyance Partners, Exceptional Ventures | 11 to 50 | 2022 |
| Alithea Genomics | Alithea Genomics develops molecular biology tools and sequencing solutions for large-scale gene expression analysis. | Biotech | Lausanne, Switzerland | Seed | $3.8M | 2026-03-04 | $9.9M | Foundation for Innovation and Technology (FIT), TechU Ventures, Eurostars +1 | 11 to 50 | 2020 |
| sable bio | Sable Bio uses artificial intelligence to analyze large biomedical datasets and test drug candidates for toxicity. | Artificial intelligence | London, United Kingdom | Seed | $3.8M | 2026-02-11 | $5.6M | Seedcamp, Episode 1 | 1 to 10 | 2023 |
| Early Health | Early Health makes consumer bathroom hardware that detects early signs of illness. | Biotech | London, United Kingdom | Seed | $4.7M | 2026-02-10 | $4.7M | LocalGlobe, SoftBank Vision Fund, Atomico +1 | 1 to 10 | 2022 |
| Biomia | Biomia develops plant-derived natural products for unmet medical needs using synthetic biology. | Biotech | Lyngby, Denmark | Seed | $3.0M | 2026-02-09 | $3.0M | BlueYard Capital, Amino Collective, Nucleus Capital | 1 to 10 | 2022 |
| Sparxell | Sparxell creates new colors and effects. | Biotech | Cambridge, United Kingdom | Seed | $5.0M | 2026-02-03 | $10.2M | Katapult, Joyance Partners, Earth Venture Capital +1 | 11 to 50 | 2022 |
| Innocent Meat | Innocent Meat provides plug-and-play technology that converts meat producers into cell-based producers. | Biotech | Rostock, Germany | Seed | $7.1M | 2026-01-22 | $11.0M | Big Idea Ventures, GENIUS Venture Capital | 1 to 10 | 2020 |
| Infinitopes | Infinitopes develops vaccines for the treatment of cancer. | Biotech | Oxford, United Kingdom | Seed | $15.4M | 2026-01-21 | $31.4M | Octopus Ventures, Kindred Capital, Martlet Capital +1 | 11 to 50 | 2021 |
| FluoSphera | FluoSphera develops drugs. | Biotech | Geneva, Switzerland | Seed | $1.4M | 2026-01-12 | $3.9M | SOSV, SOSV SF & NY (Fka IndieBio), FONGIT Innovation Fund +2 | 1 to 10 | 2021 |
| Pan Cancer T | Pan Cancer T develops T-cell receptor therapies for treating solid tumors. | Biotech | Rotterdam, The Netherlands | Seed | $5.8M | 2025-12-08 | $16.3M | InnovationQuarter, Thuja Capital, Van Herk Ventures +1 | 1 to 10 | 2020 |
| Emm | Emm develops bio-wearable devices intended to improve healthcare. | Biotech | London, United Kingdom | Seed | $8.9M | 2025-11-19 | $9.9M | Alumni Ventures, Innovate UK, Sie Ventures | 11 to 50 | 2020 |
| InvenireX | InvenireX offers molecular diagnostics services as a biotechnology company. | Biotech | Newcastle Upon Tyne, United Kingdom | Seed | $2.6M | 2025-11-18 | $3.3M | XTX Ventures, DSW Ventures | 1 to 10 | 2021 |
| The Cat Health Company | The Cat Health Company researches and develops novel therapeutics for age-related diseases in companion cats. | Biotech | Bucharest, Romania | Seed | $1.2M | 2025-10-02 | $1.8M | Early Game Ventures | 1 to 10 | 2024 |
| Hemostod | HemostOD manufactures platelets on demand from engineered stem cells. | Biotech | Lausanne, Switzerland | Seed | $5.4M | 2025-10-01 | $7.8M | Foundation for Innovation and Technology (FIT) | 11 to 50 | 2020 |
| Integra Therapeutics | Integra Therapeutics develops gene editing tools aimed at curing diseases. | Biotech | Barcelona, Spain | Seed | $3.2M | 2025-09-17 | $34.0M | EIC Accelerator, Invivo Capital Partners, Columbus Venture Partners +2 | 11 to 50 | 2020 |
Table 1. Biotech startups that raised a seed round in Europe: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 1,040.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Aptadir Therapeutics | Aptadir Therapeutics develops RNA-based therapies for Myelodysplastic Neoplasms. | Biotech | Milan, Italy | Seed | $45.5M | 2026-09-29 | $47.1M | CDP Venture Capital, Angelini Ventures | 1 to 10 | 2024 |
| 2 | Infinitopes | Infinitopes develops vaccines for the treatment of cancer. | Biotech | Oxford, United Kingdom | Seed | $15.4M | 2026-01-21 | $31.4M | Octopus Ventures, Kindred Capital, Martlet Capital +1 | 11 to 50 | 2021 |
| 3 | Tacalyx | Tacalyx develops cancer therapies that target tumor-associated carbohydrate antigens. | Biotech | Berlin, Germany | Seed | $12.9M | 2026-04-29 | $28.0M | HTGF (High-Tech Gruenderfonds), coparion, Kurma Partners +2 | 1 to 10 | 2019 |
| 4 | Omegga GmbH | Omegga GmbH develops in-ovo sexing technology that identifies male chicks before hatching to prevent their killing. | Artificial intelligence | Munich, Germany | Seed | $11.7M | 2026-04-24 | $11.7M | EIC Accelerator, GETTY | 1 to 10 | 2022 |
| 5 | Emm | Emm develops bio-wearable devices intended to improve healthcare. | Biotech | London, United Kingdom | Seed | $8.9M | 2025-11-19 | $9.9M | Alumni Ventures, Innovate UK, Sie Ventures | 11 to 50 | 2020 |
| 6 | Cellbricks Therapeutics | Cellbricks Therapeutics is a biotech company developing methods for replacing tissue and organs. | Biotech | Berlin, Germany | Seed | $8.1M | 2026-03-25 | $11.6M | b.value AG, Brooks Hill Partners | 11 to 50 | 2016 |
| 7 | Innocent Meat | Innocent Meat provides plug-and-play technology that converts meat producers into cell-based producers. | Biotech | Rostock, Germany | Seed | $7.1M | 2026-01-22 | $11.0M | Big Idea Ventures, GENIUS Venture Capital | 1 to 10 | 2020 |
| 8 | Amatera | Amatera is a biotechnology research company that develops new coffee varieties. | Biotech | Paris, France | Seed | $7.0M | 2026-03-04 | $8.6M | AgFunder, Joyance Partners, Exceptional Ventures | 11 to 50 | 2022 |
| 9 | Imperagen | Imperagen is a biotechnology company that researches enzyme engineering, artificial intelligence, and synthetic biology. | Artificial intelligence | Manchester, United Kingdom | Seed | $6.7M | 2026-05-20 | $11.0M | IQ Capital, Northern Gritstone | 11 to 50 | 2021 |
| 10 | Pan Cancer T | Pan Cancer T develops T-cell receptor therapies for treating solid tumors. | Biotech | Rotterdam, The Netherlands | Seed | $5.8M | 2025-12-08 | $16.3M | InnovationQuarter, Thuja Capital, Van Herk Ventures +1 | 1 to 10 | 2020 |
Table 2. Biotech startups that raised a seed round in Europe: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | HTGF (High-Tech Gruenderfonds) | Venture capital firm | Bonn, Germany | 34 | 3% | 2 | smartbax, Tacalyx |
| 2 | Innovate UK | Entrepreneurship program | Swindon, United Kingdom | 13 | 1% | 2 | Corryn Biotechnologies, Emm |
| 3 | Venture Kick | Startup incubator | Schlieren, Switzerland | 13 | 1% | ||
| 4 | SOSV | Venture capital firm | Princeton, United States | 9 | 1% | 2 | BioFluff, FluoSphera |
| 5 | SFC Capital | Angel group | Northwich, United Kingdom | 8 | 1% | 1 | Corryn Biotechnologies |
| 6 | Octopus Ventures | Venture capital firm | London, United Kingdom | 6 | 1% | 1 | Infinitopes |
| 7 | Bpifrance | Government investment office | Maisons-alfort, France | 6 | 1% | ||
| 8 | MassChallenge | Startup accelerator | Boston, United States | 6 | 1% | ||
| 9 | Scottish Enterprise | Government investment office | Glasgow, United Kingdom | 5 | 0% | ||
| 10 | SOSV SF & NY (Fka IndieBio) | Venture capital firm | San Francisco, United States | 4 | 0% | 2 | BioFluff, FluoSphera |
| 11 | Thuja Capital | Startup accelerator | Utrecht, The Netherlands | 4 | 0% | 2 | Tacalyx, Pan Cancer T |
| 12 | EIC Accelerator | Startup accelerator | Brussels, Belgium | 4 | 0% | 1 | Omegga GmbH |
| 13 | b.value AG | Venture capital firm | Dortmund, Germany | 4 | 0% | 1 | Cellbricks Therapeutics |
| 14 | Y Combinator | Startup accelerator | Mountain View, United States | 4 | 0% | ||
| 15 | bmp Ventures | Venture capital firm | Berlin, Germany | 4 | 0% |
Table 3. Biotech startups that raised a seed round in Europe: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 703 | 68% | $1.5B |
| Software | 199 | 19% | $396.0M |
| Artificial intelligence | 119 | 11% | $322.3M |
| Hardware | 54 | 5% | $81.1M |
| Fintech | 16 | 2% | $15.7M |
| Education | 12 | 1% | $3.6M |
| Cybersecurity | 10 | 1% | $4.7M |
| Energy | 7 | 1% | |
| Commerce | 4 | 0% | $4.7M |
Table 4. Biotech startups that raised a seed round in Europe by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Seed | 1,040 | 100% | $1.8M |
Table 5. Biotech startups that raised a seed round in Europe by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Countries
| Countries | Companies | Share |
|---|---|---|
| United Kingdom | 315 | 30% |
| France | 122 | 12% |
| Germany | 119 | 11% |
| Switzerland | 67 | 6% |
| Spain | 59 | 6% |
| The Netherlands | 56 | 5% |
| Italy | 36 | 3% |
| Denmark | 36 | 3% |
| Sweden | 33 | 3% |
| Austria | 30 | 3% |
| Ireland | 28 | 3% |
| Portugal | 26 | 2% |
Table 6. Biotech startups that raised a seed round in Europe by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 7. Biotech startups that raised a seed round in Europe by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 7 | 6% | $44.9M |
| October 2026 | 7 | 6% | $49.6M |
| September 2026 | 17 | 14% | $97.1M |
| August 2026 | 5 | 4% | $16.2M |
| July 2026 | 4 | 3% | $35.8M |
| June 2026 | 5 | 4% | $10.6M |
| May 2026 | 11 | 9% | $42.8M |
| April 2026 | 10 | 8% | $53.6M |
| March 2026 | 17 | 14% | $64.7M |
| February 2026 | 10 | 8% | $44.4M |
| January 2026 | 10 | 8% | $97.5M |
| December 2025 | 9 | 7% | $32.1M |
| November 2025 | 10 | 8% | $41.5M |
Table 8. Biotech startups that raised a seed round in Europe: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 103 | 10% | $557.0M |
| 2025 | 138 | 13% | $416.6M |
| 2024 | 120 | 12% | $400.2M |
| 2023 | 101 | 10% | $304.2M |
| 2022 | 102 | 10% | $240.8M |
| 2021 | 78 | 8% | $138.3M |
Table 9. Biotech startups that raised a seed round in Europe by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 112 | 11% |
| 2020 to 2022 | 295 | 29% |
| 2015 to 2019 | 393 | 38% |
| 2010 to 2014 | 138 | 13% |
| Before 2010 | 93 | 9% |
Table 10. Biotech startups that raised a seed round in Europe by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 644 | 63% |
| 11 to 50 | 347 | 34% |
| 51 to 100 | 14 | 1% |
| 101 to 250 | 7 | 1% |
| 251 to 500 | 5 | 0% |
| 501 to 1,000 | 1 | 0% |
| 1,001 to 5,000 | 1 | 0% |
| 5,001 to 10,000 | 1 | 0% |
| 10,001 or more | 1 | 0% |
Table 11. Biotech startups that raised a seed round in Europe by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its most recent funding round is a seed round and its headquarters is in Europe. On 16 November 2026 that is 1,040 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 30 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 1,040 rows: 331 have no round amount, 1 no city and 470 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Europe whose last round is a seed round are on the list?
- 1,040, in the file dated 16 November 2026. 122 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 1,040 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $349.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.